Pharma's Almanac | Gene Therapy

51 Articles Available

1 3

Plasmid Manufacturing

Optimizing Plasmid Production to Meet Growing Demand

PAO-04-23-NI-01

AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

PAO-01-23-CL-02

CRISPR Clinical Trial

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

PR-M04-22-11

Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

PAO-03-022-NI-08

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

PAO-02-022-CL-14

Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

PAO-02-022-CL-01

Gene Therapy

Changing Lives, One Patient at a Time

PAO-01-22-R250-16

2021 Roundup: The Year of Cell and Gene Therapy

Gene Therapy

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

PAO-10-21-CL-06

Viral Vectors

Navigating Analytical Requirements for GMP Viral Vectors

PAO-10-21-CL-02

Gene Therapy

Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing

PAO-10-21-CL-01

Gene Therapy

Pandemic Playbook for Gene Therapy Manufacturing

PAO-09-21-CL-14

Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

PAO-09-21-CL-07

Gene Therapy

Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances

Gene Therapy

Planning for Success, Addressing Quality Early for Gene Therapies

PAO-05-21-CL-02

Cell and Gene Therapy

Reducing the Risk During Cell and Gene Therapy Development and Manufacturing

PAO-03-21-CL-9

Gene Therapy

Avoiding Costly And Time-Consuming Mistakes In Gene Therapy Process Development

PAO-03-21-CL-08

Gene Therapy

Beyond 2020: Looking into the Crystal Ball for Gene Therapy

PAO-01-21-CL-03

Expansion

Colliers Completes New Headquarters Search for Rapidly Growing Gene Therapy Firm Spirovant

PR-M11-20-037

Expansion

Cognate BioServices and its Gene Therapy Division Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe

PR-M11-20-034

AAV Platform Technologies

Increasing Predictability with AAV Platform Technologies

PAP-Q4-20-CL-027

Gene Therapy

Anticipating the Next Decade of Gene Therapy

PAO-11-20-CL-02

CRISPR RNPs

CRISPR RNPs and the Future of Cell and Gene Therapy

PAP-Q3-20-CL-002

Cell & Gene Logistics

Standardizing Best Practices for Transporting Cell and Gene Therapies

PAP-Q3-20-CL-013

1 3

Gene Therapy

51 Articles Available

Can't find what you're looking for? Try our advanced search.

Plasmid Manufacturing

Optimizing Plasmid Production to Meet Growing Demand

AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

CRISPR Clinical Trial

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Gene Therapy

Changing Lives, One Patient at a Time

2021 Roundup: The Year of Cell and Gene Therapy

Gene Therapy

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

Viral Vectors

Navigating Analytical Requirements for GMP Viral Vectors

Gene Therapy

Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing

Gene Therapy

Pandemic Playbook for Gene Therapy Manufacturing

Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Gene Therapy

Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances

Gene Therapy

Planning for Success, Addressing Quality Early for Gene Therapies

Cell and Gene Therapy

Reducing the Risk During Cell and Gene Therapy Development and Manufacturing

Gene Therapy

Avoiding Costly And Time-Consuming Mistakes In Gene Therapy Process Development

Gene Therapy

Beyond 2020: Looking into the Crystal Ball for Gene Therapy

Expansion

Colliers Completes New Headquarters Search for Rapidly Growing Gene Therapy Firm Spirovant

Expansion

Cognate BioServices and its Gene Therapy Division Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe

AAV Platform Technologies

Increasing Predictability with AAV Platform Technologies

Gene Therapy

Anticipating the Next Decade of Gene Therapy

CRISPR RNPs

CRISPR RNPs and the Future of Cell and Gene Therapy

Cell & Gene Logistics

Standardizing Best Practices for Transporting Cell and Gene Therapies